Summary.-The proliferation characteristics of vascular endothelium have been studied in 131 individual experimental tumours, representing 18 transplanted tumour lines. The labelling index (LI) is high in most tumours, with a mean value of 9.Oo%, regardless of the growth rate of the tumours, or whether different tumour types are considered or individual tumours from within one line are studied in detail. A similar high LI value has been found by others for a human tumour. These high LI values may even underestimate the proliferation in new capillary buds. The high proliferative index of tumour endothelium is in marked contrast with the previously reported low 3HTdR uptake into normal tissue blood vessels. It seems likely that it is the type of new vessels formed that will influence tumour growth rates more than the simple rate of endothelial-cell proliferation. The large difference between the proliferation characteristics of tumour endothelium and normal tissue endothelium, recently identified as a possible approach for tumour therapy, has now been confirmed for a range of animal tumours and a human tumour.
THE VASCULAR NETWORK of tumours has long been known to differ from normal tissues, and to be inadequate in several aspects (for relevant reviews see Petersen, 1979) . Tumour blood vessels are less well structured, more tortuous and permeable, less innervated and spaced further apart than the vessels in most normal tissues (Egawa & Ishioka, 1979; Falk, 1978; Gullino & Grantham, 1964; Hilmas & Gillette, 1974; Mattson et al., 1979; Reinhold, 1979; Rubin & Casarett, 1966; Thomlinson & Gray, 1955; Vogel, 1965; Warren 1979a, b) . A wide variety of of techniques has been used to study the morphology (both qualitatively and quantitatively) and function of tumour blood vessels (Peterson, 1979) . These studies have indicated a considerable heterogeneity of structure and function amongst the individual vessels within 1 tumour, in the same tumour at different sizes, and amongst different tumours, whether of the same histological type or of differing histologies.
The disorganized vasculature of tumours is generally believed to result from the very rapid neovascularization that is evoked in tumours by the endogenous tumour angiogenesis factor, TAF (Folkman et al., 1971; Folkman & Cotran, 1976) . In spite of the production of many new vessels it is clear that vascular inadequacy can limit the proliferation of dependent tumour cells (Kligerman et al., 1962; Tannock, 1968; Hirst & Denekamp, 1979; Hirst et al., 1982) . Tumour cells distant from blood vessels are thought to be radioresistant because of their reduced oxygenation (Thomlinson & Gray, 1955) , and chemoresistant because of their nutritional deprivation.
In spite of the general interest in tumour blood vessels there have been only 3 studies of the proliferation rate of their component cells (Tannock, 1970; Gunduz, 1981; Hirst et al., 1982) . The scarcity of data probably results from the difficulty in recognizing endothelial cells in tumours because of the absence of endothelium-specific stains. In addition, cyclic fluctuations in blood flow through vessels may result in an inhomogeneous distribution of radioactive tracers, so that the proliferation may be heterogeneous in different regions of the tumour (Tannock & Steel, 1969; Reinhold, 1979 (Denekamp, 1982) we have undertaken a study of thymidine uptake into the endothelium of a variety of different experimental tumours. Tumours of widely different growth rates have been studied and the relationship between growth rate, tumourcell labelling and endothelial-cell labelling has been investigated.
MATERIALS AND METHODS
The labelling experiments described in this paper were performed over the period 1965- 81, but all the assessments of endothelial labelling indices have been made in 1980-81.
Some of the details of tumour-cell proliferation have been published previously, but generally without reference to the vasculature. Table I nodule. In this respect it differed from all the other tumours. There is no obvious trend in LI for either tumour cells or endothelium with increasing volume-doubling time (Table I) . These data are presented in more detail in Figs. 1-4. Fig. 1 (Steel, 1968) .
In the first kinetic study of vascular endothelium. Tannock (1970) observed that the LI of the endothelium was much lower (11-4%) No further studies of the kinetics of tumour vasculature were published until the comprehensive study of lung metastases by Gunduz (1981) . He measured the cell kinetic parameters of tumour cells and endothelium in small tumours (ranging from 0 004 to 42 mm3) using many lung nodules to obtain very large numbers of endothelial cells (600-2000 per tumour). This detailed study showed that endothelial LI was independent of tumour growth rate, i.e. similar to our present results. In some tumours the endothelial LI values were even higher than the LI values for adjacent tumour cells. He demonstrated that vascular proliferation was more than adequate for tumour growth, and was not the major reason for development of areas of necrosis. The vascular volume increased as the tumours grew, but the proportion of small "effective" capillaries fell from 990o in small tumours to only 3800 in large tumours.
Three of the tumours in the present a correction factor for the non-uniform age distribution Table I .
The endothelial LI ranged from 18% in the faster growing tumours to 4.5% in the slow-growing CA RH. The endothelial turnover rate was much slower than the potential doubling time of the tumour cells but in each case was 2-4 times faster than the tumour volume-doubling time. The authors therefore concluded that endothelial proliferation was inadequate but that vascular branching, as opposed to simple elongation of existing vessels, was a major limitation in the growth of those tumours. The 3 tumours are amongst those included in the present study (see Table I ). The published data from Tannock (T) and Gunduz (G) are summarized in Fig. 5 , together with the data from Hirst et al. (1982) and the present study. The potential doubling time for the endothelium has been calculated and plotted against the volume-doubling time for each tumour type. A solid line has been drawn to indicate equality between endothelial Tpot and tumour TD. Several points fall on this line, but most are widely scattered about it, mainly falling within the ratio 4:1 or 1:4. Thus the endothelial turnover can be faster or slower than the volume-doubling time.
Any attempt to correlate endothelial proliferation with tumour volume-doubling time contains the implicit assumption that all endothelial cells can be detected, and that all labelled endothelial cells can give rise to "effective" or useful vasculature. However, neither of these assumptions has much experimental support. Several authors (e.g. Falk, 1978; Gunduz, 1981; Hilmas & Gillette, 1974; Tannock, 1970; Tannock & Steel, 1969; Vogel, 1965; Warren, 1979a) have indicated that with increasing size the proportion of effective vasculature in the tumour decreases. This is illustrated schematically in Fig. 6 . Cell proliferation in the endothelium may give rise to wider or longer individual vessels in which the blood flow may be slowed and/or the blood will become depleted in nutrients. Furthermore, some of the endothelial cells may be lost soon (Korr et al., 1975) and in tumours (Hirst et al., 1982) . Capillary budding (Ausprunk & Folkman, 1977) (Tannock, 1968) but we were unable to obtain a better definition in autoradiographs with this stain than with conventional haematoxylin and eosin. Non-functional capillary buds extending into the tumour tissue are unlikely to be identified without more specific endothelial cell stains. These are only just becoming available, with the advent of specific monoclonal antibodies to mouse endothelium (Ghandour et al., 1982) . Such buds may represent the most important and possibly the most rapidly proliferating elements in the vasculature and attention will be focused on these in future studies. Thus LI for all these tumours is 9.0%, and the median value 7-8%. This is in marked contrast to the very low LI in normal tissue endothelium (median LI=0.22%; see summaries by Hirst et al., 1979; Denekamp, 1982) . This 35-fold difference has recently been highlighted as a potential new route for attacking tumours by means of antibody-toxin conjugates or intravascularly retained cycle-specific cytotoxic drugs (Denekamp, 1982) . It could also provide a means for diagnosing any small micrometastases which have evoked a neovasculature, using radioisotopes and imaging techniques. The present large body of data confirms that the LI values are high in almost all tumours studied regardless of their growth rates.
